about
Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytesPathobiology of the stratum corneum.The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine modelConsequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher diseaseTreatment of surfactant-damaged skin in humans with creams of different pH values.Glucosylceramide accumulates preferentially in lamellar bodies in differentiated keratinocytes.Thematic review series: skin lipids. Antimicrobial lipids at the skin surface.Basis for enhanced barrier function of pigmented skin.Fatty acids are required for epidermal permeability barrier functionKinetics of skin resealing after insertion of microneedles in human subjects.Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the ratMicro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns.Stratum corneum defensive functions: an integrated view.Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2In vivo methods for the assessment of topical drug bioavailability.The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient.Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles.Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.Skin lipids from Saudi Arabian birds.Skin biology.Characterization of microchannels created by metal microneedles: formation and closure.Epidermal barrier disorders and corneodesmosome defects.Evaluating the effectiveness of a novel atomized liquid needle-free transdermal delivery system.Sorption-desorption test for functional assessment of skin treated with a lipid system that mimics epidermal lamellar bodies.Advancements in the maintenance of skin barrier/skin lipid composition and the involvement of metabolic enzymes.Characterization of the canine skin barrier restoration following acute disruption by tape stripping.Significance of antenatal glucocorticoid exposure for pressure injury prevalence in neonates.Stratum corneum architecture, metabolic activity and interactivity with subjacent cell layers.The stratum corneum revisited.Topically applied ceramide accumulates in skin glyphsNanostructure of the stratum corneum extracellular lipid matrix as observed by cryo-electron microscopy of vitreous skin sections.Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner: Proceedings of an Expert Panel Roundtable Meeting.Skin barrier disruption by acetone: observations in a hairless mouse skin model.A Possible Percutaneous Penetration Pathway That Should Be Considered.Raman spectroscopic mapping for the analysis of solar radiation induced skin damage.Scavenger receptor class B type I is expressed in cultured keratinocytes and epidermis. Regulation in response to changes in cholesterol homeostasis and barrier requirements.Effect of chlorhexidine gluconate on the skin integrity at PICC line sites.
P2860
Q24531457-96E15747-8320-41AB-A4B2-EAD4D068DE63Q24539142-E5D82562-FCE9-4D4B-BFAF-5C201ECD377EQ28368105-110AC3BD-1525-4F6F-BAB0-668A9C17AC99Q28369639-C0FF3754-1D02-44B5-ABB2-BBCE36DA84D2Q31116897-B2ED63E3-4D67-4AB1-BFAC-97E19DD09166Q33213175-5C1F9F49-2173-4390-A3BC-7BBD85FE39C3Q34007240-F6A05B09-BB4F-4467-95BE-BF6552473E31Q34051504-3A9106E9-3642-424A-B8F6-51E2D0B11A84Q34170965-DEDA5D41-F86C-45CA-A4E7-1D6C2A00D918Q35187866-DC0BC06B-DDA6-4F5C-82DF-E47A1E9FBC4AQ35605191-465C9E95-3B8E-41D5-A990-F79FAA7680BFQ35611143-77B58AD5-0BD8-4B89-82A3-967BE4DF2E96Q36105260-EB0F5806-B4A8-42AE-AC02-74D79238119CQ36228049-949913E5-0079-41E6-9F88-15251AA19A80Q36357354-2343AA35-BA25-4476-A2FE-F90663368D88Q36412905-F499AFDC-92FD-4DE6-B3B1-AD4FEB60687CQ36587156-31B8C0BF-9E66-4104-AC0F-E91A9E34EE38Q36620344-6BC46369-AE2C-46D1-9047-B59AD577D4CBQ36941221-3E1FAB5E-E263-4BC1-A4A5-F2F9DEC7D730Q37164058-23F6106D-E4EA-4C23-81A8-AFEA2BF54F43Q37359303-7EDD635A-ECC1-47BE-ABBE-EB8133199BB6Q37618022-F6423325-6117-4727-A8A8-DE3D65EB4C85Q37986899-D3801C10-3BF7-4FB0-80B6-C0E02AF4A23EQ38254574-36620B44-A9F2-40C3-BE7C-F5A9ECF3993EQ38265975-E844AB0F-B918-40C9-AA40-F9EBC118E2A8Q38690715-FE95B1B9-1361-45BF-9690-2928B75CAF2EQ38744320-35738780-42CD-49D7-B963-532E26BF65DCQ38894252-BB01F8C1-70D7-4A27-953D-87F3FD34A155Q39673382-B48EFF89-DC02-427F-88C9-F6DA1A1E831CQ39899361-026A64F4-D769-4150-89C4-95E05684A51EQ41186834-DC3E40B9-E29E-4BC1-AFD9-31ED9157C7A0Q41303652-D6354B33-A99B-437C-9A06-50C8E2FA4E06Q41307254-546F4675-F3A8-4B98-B5A8-0AA3670C0400Q41622817-7CF40069-31C9-4D64-846B-6AEF199908D1Q41706709-446AE2AE-023F-4B71-8118-9BD77A41B6CFQ42128719-09D482F5-D368-4516-9CF4-0CFCFC12FE05Q42366828-F7DB4CDB-BDA6-47EC-8167-A09106DEAF73Q42435348-DD37B26C-AD46-42C1-A3E8-0E6738C14014Q42512833-48DA8B3C-63F8-4C6D-883F-92CF362022B0Q43289363-664B8C3E-ABD9-4D25-89C4-E10BF408DE9D
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Lamellar body secretory response to barrier disruption.
@en
Lamellar body secretory response to barrier disruption.
@nl
type
label
Lamellar body secretory response to barrier disruption.
@en
Lamellar body secretory response to barrier disruption.
@nl
prefLabel
Lamellar body secretory response to barrier disruption.
@en
Lamellar body secretory response to barrier disruption.
@nl
P2093
P1476
Lamellar body secretory response to barrier disruption.
@en
P2093
P2888
P304
P356
10.1111/1523-1747.EP12497866
P407
P577
1992-03-01T00:00:00Z
P5875
P6179
1045382977